期刊文献+

辛伐他汀对心力衰竭家兔左室收缩功能及交感活性的影响 被引量:4

Simvastatin prevents decreased left ventricular systolic dysfunction in non-ischemic heart failure in rabbits via inhibition of sympathetic activity
原文传递
导出
摘要 目的:观察辛伐他汀对心力衰竭(心衰)家兔左室收缩功能和交感活性的影响,以阐明辛伐他汀改善非缺血性心衰心功能的可能机制。方法:30只家兔随机分为3组:假手术组(10只)、心衰组(10只)、辛伐他汀干预组(10mg.kg-1.d-1,10只);心衰组和辛伐他汀干预组家兔应用超容量负荷联合压力负荷建立非缺血性心衰模型,共观察7周。利用左心导管术和心脏多谱勒观察家兔血流动力学和心脏功能的变化,采用酶联免疫吸附法测定血浆脑钠肽(BNP)、去甲肾上腺素(NE)水平,以及蛋白免疫印迹法检测心肌组织蛋白激酶A(PKA)、受磷蛋白(PLB)及第16位丝氨酸磷酸化受磷蛋白(Pser16-PLB)的蛋白表达水平。结果:①与心衰组比较,辛伐他汀干预组家兔左室舒张末压、心率、血浆BNP和NE水平明显降低(P<0.05),而左室射血分数(EF)明显增加(P<0.05);②辛伐他汀干预组家兔心肌组织PKA和Pser16-PLB表达水平较心衰组家兔明显降低(P<0.05),2组间总PLB表达无明显差别。结论:辛伐他汀具有抗交感作用,是其延缓非缺血性心衰左室收缩功能减退的可能机制之一。 Objective:To invesitigate that simvastatin would prevent the decreased left ventricular systolic dysfunction in non-ischemic heart failure(HF) in rabbits via inhibition of sympathetic activity. Method:Non-ischemic HF was induced by combined aortic valve insufficiency and aortic constriction for 7 weeks.Rabbits were assigned to HF groups treated without(n=10) or with simvastatin(10 mg·kg-1·d-1,n=10) and control group with sham operation(n=10).Cardiac function was measured using echocardiography and catheterization.Plasma norepinephrine(NE) and brain natriuretic peptide(BNP) levels were determined using ELISA assay.Protein kinase A(PKA),total phospholamban(T-PLB) and ser16-phosphorated PLB(Pser16-PLB) abundance were determined by Western blot analysis. Result:HF rabbits with simvastatin exhibited an increased ejection fraction(P0.05),in addition to a decreased LV end-diastolic pressure(P0.05),heart rate and plasma levels of NE and BNP(P0.05),compared to HF animals without treatment.Moreover,the expression of PKA(P0.05)and the ratio of Pser16-PLB to T-PLB(P0.05) were less in HF rabbits with simvastatin compared to untreated animals with HF. Conclusion:In this study,simvastatin prevents decreased left ventricular systolic dysfunction in non-ischemic heart failure in rabbits,which might be related to the inhibition of sympathetic activity.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2011年第9期705-708,共4页 Journal of Clinical Cardiology
基金 国家自然科学基金青年科学基金资助项目(No:30800460)
关键词 心力衰竭 非缺血性 辛伐他汀 儿茶酚胺 蛋白激酶A 受磷蛋白 Heart failure non-ischemia Simvastatin Norepinephrine Protein kinase A Phospholamban
  • 相关文献

参考文献4

二级参考文献31

  • 1齐志敏,张莹,王倩.大鼠心肌缺血再灌注损伤实验模型研究[J].中国临床康复,2004,8(30):6620-6621. 被引量:66
  • 2张英杰,刘仁光.大鼠急性心肌缺血早期心电图QRS波群和ST段改变[J].中国心血管病研究,2005,3(6):456-458. 被引量:23
  • 3邹操,刘志华,赵彩明,蒋彬,宋建平,杨向军,蒋廷波,杨俊华,蒋文平.超容量负荷联合压力负荷制备家兔心衰模型的可行性探讨[J].实验动物与比较医学,2005,25(4):211-214. 被引量:31
  • 4DI NAPOLI P,TACCARDI A A,GRILLI A,et al.Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts[J].Cardiovasc Res,2005,66:462-471.
  • 5JOHNS D G,AO Z,EYBYE M,et al.Rosiglitazone protects against ischemia/reperfusion-induced leukocyte adhesion in the zucker diabetic fatty rat[J].J Pharmacol Exp Ther,2005,315:1020-1027.
  • 6TIEFENBACHER C P,KAPITZA J,DIETZ V,et al.Reduction of myocardial infarct size by fluvastatin[J].Am J Physiol Heart Circ Physiol,2003,285:H59-64.
  • 7WAYMAN N S,HATTORI Y,MCDONALD M C,et al.Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size[J].FASEB J,2002,16:1027-1040.
  • 8BIRNBAUM Y,YE Y,ROSANIO S,et al.Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury[J].Cardiovasc Res,2005,65:345-55.
  • 9MENSAH K,MOCANU M M,YELLON D M.Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment:a potential role for phosphatase and tensin homolog deleted on chromosome ten[J].J Am Coll Cardiol,2005,45:1287-1291.
  • 10Asano K, Masuda K, Okumura M, et al. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation[J]. J Vet Med Sci, 2001,63(3):243-250.

共引文献42

同被引文献29

  • 1Tao NA Zhi-jiang HUANG De-zai DAI Yuan ZHANG Yin DAI.Abrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017[J].Acta Pharmacologica Sinica,2007,28(6):773-782. 被引量:10
  • 2周建华.辛伐他汀联合氨氯地平治疗舒张性心力衰竭的效果评价[J].医药前沿,2012,2(6):40-41.
  • 3Heart Protection Study Collaborative Group.Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial[J].The Lancet.2011(9808)
  • 4Marjan Mujib,Abu-Ahmed Z. Rahman,Ravi V. Desai,Mustafa I. Ahmed,Margaret A. Feller,Inmaculada Aban,Thomas E. Love,Michel White,Prakash Deedwania,Wilbert S. Aronow,Gregg Fonarow,Ali Ahmed.Warfarin Use and Outcomes in Patients With Advanced Chronic Systolic Heart Failure Without Atrial Fibrillation, Prior Thromboembolic Events, or Prosthetic Valves[J].The American Journal of Cardiology.2011(4)
  • 5S. Agewall.The large clinical statin trials[J].International Journal of Cardiology.2011(1)
  • 6Timo E Strandberg.Lipid-lowering drugs and heart failure: where do we go after the statin trials?[J].Current Opinion in Cardiology.2010(4)
  • 7Sandra Erbs,Ephraim B. Beck,Axel Linke,Volker Adams,Stephan Gielen,Nicolle Kr?nkel,Sven M?bius-Winkler,Robert H?llriegel,Holger Thiele,Rainer Hambrecht,Gerhard Schuler.High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling — Results from a randomized, double-blind, and placebo-controlled study[J].International Journal of Cardiology.2010(1)
  • 8Shin-ichiro Miura,Keijiro Saku.Effects of statin and lipoprotein metabolism in heart failure[J].Journal of Cardiology.2010(3)
  • 9Lei Zhang,Shuning Zhang,Hong Jiang,Aijun Sun,Yunkai Wang,Yunzeng Zou,Junbo Ge,Haozhu Chen.Effects of Statin Therapy on Inflammatory Markers in Chronic Heart Failure: A Meta-analysis of Randomized Controlled Trials[J].Archives of Medical Research.2010(6)
  • 10Cholesterol Treatment Trialists’ (CTT) Collaborators.Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis[J].The Lancet.2008(9607)

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部